This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2005 Jun;128(7):2161-4.

doi: 10.1053/j.gastro.2005.04.019.

Infliximab for ulcerative colitis: finally some answers

PMID: 15940648
DOI: 10.1053/j.gastro.2005.04.019

Editorial

Infliximab for ulcerative colitis: finally some answers

Geert D'Haens. Gastroenterology. 2005 Jun.

. 2005 Jun;128(7):2161-4.

doi: 10.1053/j.gastro.2005.04.019.

Author

PMID: 15940648
DOI: 10.1053/j.gastro.2005.04.019

No abstract available

PubMed Disclaimer

Comment in

Infliximab or cyclosporine for severe ulcerative colitis.
Hanauer SB. Hanauer SB. Gastroenterology. 2005 Oct;129(4):1358-9; author reply 1359. doi: 10.1053/j.gastro.2005.08.040. Gastroenterology. 2005. PMID: 16230092 No abstract available.

Comment on

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.
Järnerot G, Hertervig E, Friis-Liby I, Blomquist L, Karlén P, Grännö C, Vilien M, Ström M, Danielsson A, Verbaan H, Hellström PM, Magnuson A, Curman B. Järnerot G, et al. Gastroenterology. 2005 Jun;128(7):1805-11. doi: 10.1053/j.gastro.2005.03.003. Gastroenterology. 2005. PMID: 15940615 Clinical Trial.

Similar articles

Infliximab for ulcerative colitis.
Reinshagen M. Reinshagen M. N Engl J Med. 2006 Mar 30;354(13):1424-6; author reply 1424-6. N Engl J Med. 2006. PMID: 16575949 No abstract available.
Infliximab for ulcerative colitis.
Simmons J, Jewell DP. Simmons J, et al. Dig Liver Dis. 2002 Sep;34(9):616-8. doi: 10.1016/s1590-8658(02)80201-8. Dig Liver Dis. 2002. PMID: 12405245 No abstract available.
Infliximab efficacy in pediatric ulcerative colitis.
Eidelwein AP, Cuffari C, Abadom V, Oliva-Hemker M. Eidelwein AP, et al. Inflamm Bowel Dis. 2005 Mar;11(3):213-8. doi: 10.1097/01.mib.0000160803.44449.a5. Inflamm Bowel Dis. 2005. PMID: 15735427 Clinical Trial.
[Golimumab Therapy in Ulcerative Colitis].
Moon W. Moon W. Korean J Gastroenterol. 2016 Feb;67(2):64-73. doi: 10.4166/kjg.2016.67.2.64. Korean J Gastroenterol. 2016. PMID: 26907481 Review. Korean.
Anti-tumour necrosis factor therapy for ulcerative colitis: evidence to date.
Thukral C, Cheifetz A, Peppercorn MA. Thukral C, et al. Drugs. 2006;66(16):2059-65. doi: 10.2165/00003495-200666160-00002. Drugs. 2006. PMID: 17112300 Review.

See all similar articles

Cited by

Clinical pharmacokinetics and use of infliximab.
Klotz U, Teml A, Schwab M. Klotz U, et al. Clin Pharmacokinet. 2007;46(8):645-60. doi: 10.2165/00003088-200746080-00002. Clin Pharmacokinet. 2007. PMID: 17655372 Review.
Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis.
Berends SE, Strik AS, Löwenberg M, D'Haens GR, Mathôt RAA. Berends SE, et al. Clin Pharmacokinet. 2019 Jan;58(1):15-37. doi: 10.1007/s40262-018-0676-z. Clin Pharmacokinet. 2019. PMID: 29752633 Free PMC article. Review.
The use of traditional and newer calcineurin inhibitors in inflammatory bowel disease.
Naganuma M, Fujii T, Watanabe M. Naganuma M, et al. J Gastroenterol. 2011 Feb;46(2):129-37. doi: 10.1007/s00535-010-0352-z. Epub 2010 Dec 4. J Gastroenterol. 2011. PMID: 21132334 Review.
Review and clinical perspectives for the use of infliximab in ulcerative colitis.
Panaccione R, Fedorak RN, Aumais G, Bernard EJ, Bernstein CN, Bitton A, Croitoru K, Dieleman LA, Enns R, Feagan BG, Franchimont D, Greenberg GR, Griffiths AM, Marshall JK, Pare P, Patel S, Penner R, Render C, Seidman E, Steinhart AH. Panaccione R, et al. Can J Gastroenterol. 2008 Mar;22(3):261-72. doi: 10.1155/2008/493405. Can J Gastroenterol. 2008. PMID: 18354755 Free PMC article. Review.
Advances in biologic therapy for ulcerative colitis and Crohn's disease.
D'Haens G, Daperno M. D'Haens G, et al. Curr Gastroenterol Rep. 2006 Dec;8(6):506-12. doi: 10.1007/s11894-006-0041-5. Curr Gastroenterol Rep. 2006. PMID: 17105690 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information